Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
Keep the sparks coming! Delegates of the conference have access to on-demand content until the end of October 2021.
This updated edition is a great reference for anyone working in multinational product development and marketing.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 24 October 2016 | By Zachary Brennan
The European Medicines Agency (EMA) on Monday said that marketing authorization holders (MAHs) need to submit any minor changes to drug marketing authorizations, also known as Type IAIN and Type IA variations, for 2016 by 30 November.
MAHs are also advised to submit any Type IB variations or groupings of Type IB and Type IA variations in 2016 by 13 December 2016. The deadlines have been set so that EMA can acknowledge the validity of the submissions before the agency's closure between 23 December 2016 and 2 January 2017, and within the 30-day timeframe set by the regulations.
The agency warns that for submissions received on or after 14 December 2016, the acknowledgment procedure may not start until January 2017.
Type IAIN and IA variations have no impact on the quality, safety or efficacy of the medicine. Type IAINmust be sent to the national competent authority or EMA immediately following implementation, in order to ensure the continuoussupervision of the medicine, whereas Type IA variations do not require immediate notification and should be sent to the national competent authority or EMA within 12 months of implementation, or earlier in certain cases.
Type IB variations must be sent to the national competent authority or EMA before implementation, but do not require a formal approval. Upon acknowledgement of a valid notification, the MAH must wait 30 days to ensure that the notification is deemed acceptable by the national competent authority or EMA before implementing the change.
For procedural or regulatory inquiries on these procedures for human medicines, EMA says MAHs can email iaquery@ema.europa.eu or ibquery@ema.europa.eu.
Tags: Type I variations, EMA deadlines
Regulatory Focus newsletters
All the biggest regulatory news and happenings.